Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
We outline common circumstances where index funds may be preferable to ETFs, including buy-and-hold strategies and simplicity.
25,141 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A high-profile insider sale can spark questions about a company’s future. This article breaks down the HeartFlow CEO'...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
A Speedway employee admitted to processing fake coffee refunds that drained thousands from the chain. The case highli...
Lower-priced metros stay resilient as demand cools amid elevated rates. This loans-focused update surveys July data a...
A Capitol Hill hearing put Meta under sharp scrutiny over its teen and tween targeting. Lawmakers demanded tighter sa...
Bitcoin's Divergence From Nasdaq raises questions about dollar liquidity and credit conditions. This article breaks d...
A landmark ruling reshapes trade policy and could alter stock market dynamics. This guide breaks down what happened, ...
The Supreme Court’s Feb. 20 decision voids the tariff program, setting up a possible $175 billion refunds wave that c...
Investors preparing for the Q4 2025 call on tarsus (tars) 2025 earnings will want a clear, actionable plan. This guid...
Amazon disclosed a record $200 billion capital expenditure plan for 2026, prompting investor questions about the time...